Sort
10,829 grants matching “car t”
Functional Genomics of Chemical -Induced Acute Lung Injury
$713,952George Douglas Leikauf · University Of Pittsburgh At Pittsburgh · U01 · FY2010 · ES
The Virtual Fitness Buddy Ecosystem: Using Digital Technology to Promote and Sustain Moderate-to-Vigorous Intensity Physical Activity in Children
$713,920Sun Joo Joo Ahn · University Of Georgia · R01 · FY2017 · HL
PET IN HYPERKINETIC DISORDERS--A MULTICENTER STUDY
$713,276North Shore University Hospital · R01 · FY2000 · NS
Optimizing Hematopoietic Stem Cell Transplantation For The Treatment Of Hematological Malignancies
$713,138John F Dipersio · Washington University · R35 · FY2025 · CA
Evaluation of mHealth strategies to optimize adherence and efficacy of PMTCT/ART
$713,099Grace C John-Stewart · University Of Washington · R01 · FY2017 · HD
Clinical Interventional Studies of HIV Reservoirs
$713,000Frank Maldarelli · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Healthy for 2/Healthy for U: A Pragmatic Randomized Clinical Trial to Limit Gestational Weight Gain and Prevent Obesity in the Prenatal Care Setting
$712,959Wendy Lynet Bennett · Johns Hopkins University · R18 · FY2022 · DK
Ten-Fold Resolution Boost for Magnetic Particle Imaging with Applications to Rapid, Non-Invasive Imaging of CAR-T Cell Therapies, Stroke, GI Bleeds and Pulmonary Embolisms
$712,953Steven M Conolly · University Of California Berkeley · U01 · FY2023 · EB
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$712,796Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
A phase I/II combination immunotherapy clinical trial: mesothelin-targeted chimeric antigen receptor T cells and checkpoint blockade agent in pleural mesothelioma
$712,796Prasad S. Adusumilli · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Preclinical development of CM-CX1 for the treatment of ovarian clear cell and renal cell carcinomas
$712,718Joana M Murad · Celdara Medical, Llc · R44 · FY2022 · CA
Carbohydrate Antigen-bearing Nanoparticles for Antitumor Therapy
$712,618Joseph John Barchi · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
The Use of Blood Cells and Optical Cerebral Complex IV Redox States in a Porcine Model of CO Poisoning with Evaluation of Mitochondrial Therapy
$712,135David H Jang · University Of Pennsylvania · R01 · FY2025 · HL
DEVELOPMENT OF A GPC2 CAR T CELL-AMPLIFYING EXTRACELLULAR VESICLE VACCINE
$712,000The Children'S Hospital Of Philadelphia · · FY2025 · Defense Health Agency
Targeting CD83 to reduce leukemia relapse and GVHD after allogeneichematopoietic cell transplantation
$711,892Brian C Betts · Roswell Park Cancer Institute Corp · R01 · FY2025 · HL
Clinical Evaluation of Chlorotoxin-redirected Chimeric Antigen Receptor (CAR) T cells for Treatment of Glioblastoma
$711,759Christine Brown · Beckman Research Institute/City Of Hope · R01 · FY2024 · CA
Amyloid Beta CAR Macrophages: a cell engineering strategy to clear pathogenic proteins
$710,765Saar Gill · University Of Pennsylvania · R01 · FY2023 · NS
Personalized Digital Behavior Change Interventions to Promote Oral Health
$710,574Vivek Shetty · University Of California Los Angeles · UH3 · FY2022 · DE
Child Health Initiative for Lifelong Eating and Exercise (CHILE)
$710,536Sally Melinda M Davis · University Of New Mexico · R01 · FY2009 · DK
Intracerebroventricular (ICV) Administration of CD19-Targeting Chimeric Antigen Receptor (CAR) T cells for Treatment of Primary Central Nervous System Lymphoma
$710,483Xiuli Wang · Beckman Research Institute/City Of Hope · R01 · FY2025 · CA
A spatial profiling-based immune hub perturbation platform to improve immunotherapy in colon cancer
$710,361Karin Pelka · J. David Gladstone Institutes · R37 · FY2025 · CA
ANDROGEN METABOLISM IN CHILDHOOD
$710,354Mount Sinai School Of Medicine Of Nyu · R37 · FY2005 · HD
Preclinical development and clinical monitoring of adoptive immune therapy
$710,207Francis Flomerfelt · Division Of Basic Sciences - Nci · ZIC · FY2022 · CA
Therapeutic targeting of human islets with recombinant regulatory T cells
$709,922Seung K Kim · Stanford University · U01 · FY2022 · DK
SBIR Phase II: Reflectance Sensitive Image Sensor for Illumination-Invariant Visual Perception
$709,907Vladimir M Brajovic · Intrigue Technologies, Inc. · · FY2005 · TIP